Role of LMCD1 in the Long-Term Effects of Angiotensin II in Vascular Smooth Muscle Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094053 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Janka Borbála Gém und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Semmelweis University, Tűzoltó utca 37-47, 1094 Budapest, Hungary. Hauptthemen laut MEDLINE: Angiotensin II, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, LIM Domain Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian National Research, Development and Innovation Fund, Semmelweis University, Hungarian National Research, Development, and Innovation Fund.
Abstract (Originalsprache)
Excessive activity of the hormone angiotensin II (AngII) is known to contribute to the pathogenesis of multiple cardiovascular diseases, including atherosclerosis, vascular remodeling, and hypertension, primarily through inducing gene expression changes. In this study, we identified LMCD1 (LIM and cysteine-rich domains 1, also known as Dyxin), primarily recognized as a transcription co-factor involved in various oncogenic processes, cardiac hypertrophy, and vascular remodeling, as a potential key factor in AngII-mediated effects in vascular smooth muscle cells (VSMCs). We demonstrated that AngII upregulates LMCD1 expression in primary rat VSMCs through type 1 angiotensin receptor (AT1-R) activation, leading to calcium signaling and p38 MAPK pathway activation. Additionally, we also demonstrated in A7r5 vascular smooth muscle cells that LMCD1 protein overexpression results in enhanced cell proliferation and cell migration. Our findings provide insights into the mechanisms by which AngII mediates changes in LMCD1 expression. The elevated expression of LMCD1 enhanced the cell proliferation and migration in VSMCs in vitro experiments, suggesting that LMCD1 may be an important factor in vascular remodeling and the pathogenesis of severe cardiovascular diseases. These results raise the possibility that LMCD1 could be a promising pharmacological target in the cardiovascular dysfunctions associated with AT1-R overactivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Semmelweis University, Tűzoltó utca 37-47, 1094 Budapest, Hungary.
- Institute of Molecular Life Sciences, Centre of Excellence of the Hungarian Academy of Sciences, HUN-REN-SU Research Centre of Natural Sciences, Magyar tudósok körútja 2, 1117 Budapest, Hungary.
- Department of Internal Medicine and Haematology, Semmelweis University, 1088 Budapest, Hungary.
- HUN-REN-SU Molecular Physiology Research Group, Hungarian Research Network and Semmelweis University, 1094 Budapest, Hungary.
ORCID-Profile: Szilvia Barsi, Amir Damouni, András Dávid Tóth, Péter Várnai, László Hunyady
Förderung
- Hungarian National Research, Development and Innovation Fund
- Semmelweis University
- Hungarian National Research, Development, and Innovation Fund
Zitieren
APA
Gém, J. B., Kovács, K. B., Barsi, S., Hadadnejadtehrani, S., Damouni, A., Turu, G., Tóth, A. D., Várnai, P., Hunyady, L., & Balla, A. (2025). Role of LMCD1 in the Long-Term Effects of Angiotensin II in Vascular Smooth Muscle Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094053
Vancouver
Gém JB, Kovács KB, Barsi S, Hadadnejadtehrani S, Damouni A, Turu G, et al. Role of LMCD1 in the Long-Term Effects of Angiotensin II in Vascular Smooth Muscle Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094053
BibTeX
@article{Gm2025,
author = {Gém, Janka Borbála and Kovács, Kinga Bernadett and Barsi, Szilvia and Hadadnejadtehrani, Saba and Damouni, Amir and Turu, Gábor and Tóth, András Dávid and Várnai, Péter and Hunyady, László and Balla, András},
title = {Role of LMCD1 in the Long-Term Effects of Angiotensin II in Vascular Smooth Muscle Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094053}
}
EUVIMED